TriMas Co. (NASDAQ:TRS - Free Report) - Analysts at Zacks Research lowered their FY2024 earnings per share estimates for shares of TriMas in a research report issued to clients and investors on Monday, November 18th. Zacks Research analyst M. Das now forecasts that the industrial products company will post earnings per share of $1.70 for the year, down from their previous estimate of $1.81. The consensus estimate for TriMas' current full-year earnings is $1.74 per share. Zacks Research also issued estimates for TriMas' Q4 2024 earnings at $0.47 EPS, Q1 2025 earnings at $0.44 EPS, Q2 2025 earnings at $0.53 EPS, Q4 2025 earnings at $0.47 EPS, FY2025 earnings at $2.02 EPS, Q1 2026 earnings at $0.57 EPS, Q2 2026 earnings at $0.61 EPS and Q3 2026 earnings at $0.63 EPS.
TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). The company had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company's revenue was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.57 earnings per share.
Other research analysts have also recently issued reports about the company. StockNews.com raised TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th. BWS Financial restated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Tuesday, November 5th.
View Our Latest Stock Report on TRS
TriMas Stock Down 0.2 %
Shares of TRS stock traded down $0.05 on Wednesday, hitting $26.16. 34,568 shares of the stock were exchanged, compared to its average volume of 267,393. The firm has a market capitalization of $1.06 billion, a P/E ratio of 40.95 and a beta of 0.66. The business has a 50-day moving average of $26.20 and a 200 day moving average of $25.85. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. TriMas has a fifty-two week low of $22.45 and a fifty-two week high of $28.51.
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend was Tuesday, November 5th. TriMas's dividend payout ratio is 25.00%.
Institutional Trading of TriMas
A number of institutional investors have recently bought and sold shares of the business. Innealta Capital LLC bought a new stake in shares of TriMas in the second quarter valued at approximately $26,000. Aristides Capital LLC acquired a new position in TriMas in the 2nd quarter valued at $245,000. Intech Investment Management LLC bought a new stake in shares of TriMas during the 3rd quarter valued at $269,000. Paloma Partners Management Co acquired a new stake in shares of TriMas during the 3rd quarter worth $293,000. Finally, XTX Topco Ltd bought a new position in shares of TriMas in the third quarter worth $371,000. Institutional investors own 99.42% of the company's stock.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
